Immature granulocytes may signal pediatric lupus activity

• by Andrea Surnit

• November 5, 2026

Clinical features and outcomes of patients with anti-neutrophil cytoplasmic antibody-positive systemic lupus erythematosus from a single-center retrospective study

• by Magdalena Morytko, Radosław Dziedzic, Lech Zaręba, Mariusz Korkosz, Joanna Kosałka-Węgiel

• July 13, 2026

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

• by Kathryn Wighton

• August 28, 2026

• 5 min

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min